Compare Cigna Corp (CI) vs Microsoft (MSFT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Microsoft — how do they compare? Cigna Corp trades at $271.91 (market cap $73.56B), while Microsoft trades at $502.51 (market cap $3.76T). The key difference: Microsoft is far larger — about 51.1× Cigna Corp's market cap, and Cigna Corp pays the higher dividend (2.24%). Which is the better fit depends on your goals.
| CI | MSFT | |
|---|---|---|
Market Cap | $73.56B | $3.76T |
Sector | Health | Technology |
52-Week High | $311.00 | $542.07 |
52-Week Low | $244.41 | $352.83 |
Enterprise Value | $98.27B | $3.74T |
Dividend Yield | 2.24% | 0.72% |
Volume | — | 36,654,621 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
Microsoft (MSFT) trades at $501.28, up 0.26% on the day, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $4.74 exceeding the $4.24 forecast. Revenue growth is robust, reaching $281.72 billion in 2025, with a net income margin of 40.31%. Analyst sentiment is overwhelmingly positive, with 80.49% recommending Buy and a consensus price target of $553.70.
The outlook for MSFT remains favorable, driven by AI leadership, Azure cloud momentum, and solid financials. Key risks include elevated capital expenditure concerns and competitive pressures. With a P/E of 28.19, the valuation is premium but supported by growth. Institutional ownership trends and recent dividend actions underscore confidence, though investors should monitor execution on AI investments and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Microsoft
Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
Read more on MSFT →
